京津冀“3+N”联盟集采启动：西药、中成药带量联动采购，推动仿制药企业加大研发投入

七印授权

4YKO1668NS6PVFWK2SN7KLS9FCMS35R9Q9O59A2TFJVE2TMN0A

2023-09-06 09:41:58

article

54B420A6D86638BDB9F0E510D86401329E781E9206786930EA9A192730AC2521

zh-CN

810C6AC3DBE42EC737C2BFAC2D1B6C124E284D4A

15203703

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

d660ac3014f96af516b393046ef4b9b57f183329027a47d22fa7a4a43ae0487674a4887989f734ec659d680c39239c913840615b2297798735f1d12d23d708751c

{"parameters":{"adaptation":"n","authorized":"七印信息科技","price":"180000"},"type":"cm"}

yuanben_64f849663d0f93.76280701

原本认证

4ML03HUC804GOS1C7B48L3ELUGBY2XL8MIK68982TG2ZCH7SEE

https://www.yuanben.io/article/c4323459-087d-420d-bdfc-f292d07d0e27

{"author":"广东南方财经控股有限公司","authorization_pub_key":"03db333a8335fc94ab2e27ec5b937827ece2e576ae219f93ea1083a9a4f8882dc2"}